Research Paper Volume 13, Issue 6 pp 8408—8420

Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy

The PFS (Left) and OS (Right) of the whole cohort.

Figure 1. The PFS (Left) and OS (Right) of the whole cohort.